Artículos del autor

solaci

Structural heart disease

COAPT: Promising 5-Year Outcomes

Secondary ischemic and non-ischemic mitral valve failure (SMR), produce left ventricle dilation, papillary muscle displacement, and impaired...
solaci -
Femoral

TAVR: Vascular Access in Patients with Peripheral Artery Disease, 1-Year Outcomes

At present, the transfemoral access (TFA) is the preferred approach when it comes to transcatheter aortic valve...
solaci -
Coronary disease

Vascular Ultrasound in Percutaneous Closure Devices: Subanalysis of the UNIVERSAL-Trial

Analysis of percutaneous closure device placement when choosing an ultrasound-guided vs. a fluoroscopy-guided femoral approach. Transradial access is...
solaci -
Other

ACC 2023 | COORDINATE-DIABETES

Approximately only 2.7% of all diabetic patients with ischemic heart disease in the United States receive optimal...
solaci -
Other

ACC 2023 | A DUE-Study (Phase III)

In pulmonary hypertension (PHT), 10 mg macitentan plus 40 mg tadalafil is recommended as a safe combination therapy for...
solaci -
Acute coronary syndromes

ACC 2023 | Ultrasensitive Troponin I Monitoring with a Transdermal Wrist Device

Over the years, early diagnosis of myocardial ischemia has ranged from 0-to-3-h protocols to abbreviated guidelines with...
solaci -
Other

ACC 2023 | PULSE-AF

Catheter ablation is an effective treatment for patients with atrial fibrillation (AF) refractory to the standard medical...
solaci -
Chronic Coronary Syndromes

Mechanical Aspiration in ST Elevation ACS

In ST elevation ACS the preferred treatment is primary PCI. However, one its limitations is thrombus presence...
solaci -